Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters’ countries
ID
Tachkov, Konstantin
(
Author
),
ID
Somolinos-Simón, Francisco
(
Author
),
ID
Hren, Rok
(
Author
),
ID
Došenović Bonča, Petra
(
Author
), et al.
PDF - Presentation file,
Download
(1,58 MB)
MD5: FF193E0A57B4DFD834E7F89652885FBA
URL - Source URL, Visit
https://www.tandfonline.com/doi/full/10.1080/13102818.2024.2371354
Image galllery
Abstract
This study aimed to investigate the transferability of novel artificial intelligence (AI) methods for prediction modelling of diabetes based on real-world data (RWD) between early and late adopters of emerging health technologies from the perspective of developers and health technology assessment (HTA) experts. A two-step approach was used. Developers of the new AI methods within HTx consortium completed a survey about the benefits, usability, barriers associated with implementing the new prediction models in routine HTA practices. Then, HTA experts from Central and Eastern European (CEE) countries participated in a focus group discussion. Developers generally expressed optimism regarding the transferability of the methods, while acknowledging potential disparities across CEE countries. Key benefits that were identified included enhanced understanding of diabetes, improved cost-effectiveness modelling, and refined patient stratification, all of which could contribute to clinical and reimbursement decisions across various jurisdictions. The focus group underscored the value of real-world data for diabetes prediction modelling, serving as a beneficial resource for both clinicians and HTA agencies. However, there was a recognized need to clarify the processes of integrating randomized clinical trial data with real-world data. For the other stakeholders, the advancement of the methodology will improve the diagnosis and therapy during the process of decision making. Experts from CEE countries recognized the potential of artificial intelligence-based methods employing real-world data for diabetes modelling. These methods are seen as instrumental in elucidating the heterogeneous nature of the disease, supporting clinician decision-making and holding promises for HTA purposes.
Language:
English
Keywords:
Central and Eastern Europe
,
artificial intelligence
,
knowledge transfer
,
health
,
transferability
,
health technology assessment
,
Central and Eastern European countries
,
diabetes
,
artificial intelligence
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
EF - School of Economics and Business
FMF - Faculty of Mathematics and Physics
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
9 str.
Numbering:
Vol. 38, iss. 1, article no. 2371354
PID:
20.500.12556/RUL-169986
UDC:
614.2
ISSN on article:
1310-2818
DOI:
10.1080/13102818.2024.2371354
COBISS.SI-ID:
200278019
Publication date in RUL:
30.06.2025
Views:
634
Downloads:
219
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Biotechnology & biotechnological equipment
Shortened title:
Biotechnol. Biotechnol. Equip.
Publisher:
Taylor & Francis
ISSN:
1310-2818
COBISS.SI-ID:
9120084
Licences
License:
CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:
http://creativecommons.org/licenses/by-nc/4.0/
Description:
A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Secondary language
Language:
Slovenian
Keywords:
srednja in vzhodna Evropa
,
umetna inteligenca
,
prenos znanja
,
zdravje
Projects
Funder:
EC - European Commission
Funding programme:
H2020
Project number:
825162
Name:
Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe
Acronym:
HTx
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back